Each 1 mL (33 drops) contains tincture of:
Fresh organically grown* Purple Coneflower (Echinacea purpurea)
Herb (1:12) ...0.95 mL (860mg), equivalent to 72 mg dried herb;
Root (1:11) ...0.05 mL (45mg), equivalent to 4.1 mg dried root.
1 mL of tincture contains 0.67 mL alcohol (ethanol).
1 mL = 33 drops. Dropper included
Clinically shown to help prevent and relieve the symptoms of upper respiratory tract infections (URTI) such as the common cold and flu. Shortens the duration of URTI. Used in Herbal Medicine to support the immune system, especially in times of stress, lack of sleep and for smokers. Take at first sign of infection.
50mL and 100 mL
Adults including pregnant and breastfeeding women ( 12 and over): Take 30 drops with water, 3 times daily for prevention and 5 times daily for acute treatment, 15 minutes before meals.
Insalivate before swallowing.
Duration of use: May be used up to 4 months.
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have a progressive systemic disease such as tuberculosis, leukosis, collagenosis or multiple sclerosis, or if you are taking immunosuppressants.
Do not use if you are allergic to plants of the Asteraceae / Compositae / Daisy family. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use.
Do not use if security cap is broken. Keep out of reach of children.
1. Burger Ra, Torres AR, Warren RP et al. Echinacea-induced cytokine by human macrophages. Int J Immunopharmacol 1997;19(7):371-9.
2. Lin Z, Neamati N, Zhao H et al. Chicoric acid analogues as HIV-1 integrase inhibitors. J Med Chem 1999;42(8):1401-14.
3. Facino RM, Carini M, Aldini G et al. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of Echinacea extracts in the prevention of skin photodamage. Planta Med 1995;61(6):510-4.
4. Gunning K. Echinacea in the treatment and prevention of upper respiratory tract infections. West J Med 1999;171:198-200.
5. Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999;48:628-35.
6. Grimm W, Muller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999;106:138-43.
7. Barrett B, Vohmann M et Calabrese C. Echinacea for Upper respiratory infections. J Fam Pract 1999;48(8):628-35.
8. Degenring FH, Enquête sur l'efficacitÉ thÉrapeutique d'Echinaforce®. Ganzheits Medizin 1995;2:88-94.
9. Brinkeborn R, Shah D, GeissbÜhler S et al. Echinaforce® dans le traitement des États grippaux aigus. Ganzheits Medizin 1998;10(1):26-29.
10. Gallo M, Sarkar M, Au W et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med 2000;160(20):3141-3.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.